52 Week Range
As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
Hitachi Chemical To Acquire Apceth Biopharma GmbH
Thai Storage Battery Enters License Agreement With Hitachi Chemical
Hitachi Chemical Advanced Therapeutics Solutions Says Signed A Three-Year Clinical Manufacturing Agreement With GSK
Hitachi Chemical Company, Ltd. is mainly engaged in the manufacture, process and sale of functional materials, advanced components and systems. The Company operates in two segments. The Functional Materials segment provides electronic materials such as semiconductor die bonding materials and epoxy molding compounds, electrical insulating varnishes; inorganic materials such as carbon products and others; resin materials such as adhesive films, films for display circuit connection and others, and wiring board materials such as copper clad laminates and photo-sensitive films. The Advanced Component and System segment offers automobile parts such as resin molded articles, friction materials and powder metallurgy products; storage devices and systems such as vehicle batteries and industrial batteries and systems; electronic components including wiring boards, as well as other products such diagnostic equipment.
7F, GRANTOKYO SOUTH TOWER
Chairman of the Board
Executive President, Representative Executive Officer, Chief Executive Officer, Director
Senior Managing Executive Officer, Director
Managing Executive Officer
Managing Executive Officer
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
Japan's Hitachi Ltd <6501.T> has narrowed suitors for its $6.8 billion chemical unit to a handful of companies including Bain Capital and Carlyle Group LP <CG.O>, people with knowledge of the deal said.
Japan's Hitachi Ltd has narrowed suitors for its $6.8 billion chemical unit to a handful of companies including Bain Capital, Japan Industrial Partners and Nitto Denko Corp, four people with knowledge of the deal said.
* Says co forms business alliance with Hitachi Chemical Co Ltd and its unit Hitachi Chemical Advanced Therapeutics Solutions, LCC, regarding manufacturing of SB623
* Hitachi chemical signs agreement to purchase from caladrius biosciences remaining 80.1% interest in percent for $75 million Source text for Eikon: Further company coverage:
* Bluejay Diagnostics announced collaborative clinical research agreement with Hitachi Chemical to develop a non-invasive, point-of-care test Source text for Eikon: Further company coverage: (Bangalore.email@example.com)
The following are mergers under review by the European Commission and a brief guide to the EU merger process:
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.